oxoline has been researched along with lonapalene in 1 studies
Studies (oxoline) | Trials (oxoline) | Recent Studies (post-2010) (oxoline) | Studies (lonapalene) | Trials (lonapalene) | Recent Studies (post-2010) (lonapalene) |
---|---|---|---|---|---|
12 | 0 | 2 | 18 | 2 | 1 |
Protein | Taxonomy | oxoline (IC50) | lonapalene (IC50) |
---|---|---|---|
Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 0.6467 | |
5-lipoxygenase | Bos taurus (cattle) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berks, AH; Jones, GH; Kruseman, M; Loe, BE; Maloney, PJ; Murthy, DV; Simpson, RA; Spires, DA; Venuti, MC; Young, JM | 1 |
1 other study(ies) available for oxoline and lonapalene
Article | Year |
---|---|
Topical nonsteroidal antipsoriatic agents. 1. 1,2,3,4-Tetraoxygenated naphthalene derivatives.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Topical; Animals; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Biological Assay; Edema; Female; Humans; Lipoxygenase Inhibitors; Mice; Naphthalenes; Neutrophils; Ornithine Decarboxylase Inhibitors; Oxygen; Psoriasis; Structure-Activity Relationship; Tetrahydronaphthalenes | 1986 |